Suggestions

Psychedelic News
DMT
Ketamine
Mescaline
Psilocybin
CEO INTERVIEWS

WiTheme

Search

Recent Posts

Choose Ketamine Complete Capital Raise to Expand Technology Platform
Biomind Labs Secure FDA Pre-IND Meeting for Feedback on NCE Triptax
Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment
Numinus Develop Psilocybin Mushroom Tea Bags for Psychedelic Research Use
atai Life Sciences Announce First Subject Dosed in Synthetic DMT Phase 1 Trial

Recent Comments

No comments to show.

Popular

Choose Ketamine Complete Seed Capital Raise to Expand Technology Platform

Choose Ketamine Complete Capital Raise to Expand Technology Platform

In a major milestone for mental health care, Austin-based Choose

Biomind Labs Secure Pre-IND Meeting, Seek FDA Feedback on New Triptax Depression Treatment

Biomind Labs Secure FDA Pre-IND Meeting for Feedback on NCE Triptax

The well-known psychedelic biotech company Biomind Labs Inc. (NEO: BMND)

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment

Silo Pharma (Nasdaq: SILO), a developmental-stage psychedelic biopharmaceutical firm, announced

© 2022 PSYCHEDELIC CHRONICLE
ALL RIGHTS RESERVED.

Psychedelic News
DMT
Ketamine
Mescaline
Psilocybin
CEO INTERVIEWS